-
Mashup Score: 0Women exhibit lower response to advanced therapies for axial spondyloarthritis vs men - 1 day(s) ago
Women with axial spondyloarthritis are less likely than men to respond to multiple different classes of advanced therapies, according to a systematic review and meta-analysis published in Arthritis Care & Research.“Observational studies indicate that female patients with [axial SpA] have a significantly lower treatment response and are less likely to achieve low disease activity
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 4Staying ‘as mobile as possible’ critical to curbing osteoporosis in rheumatoid arthritis - 2 day(s) ago
Managing rheumatoid arthritis-associated osteoporosis requires an ongoing, multidisciplinary effort to prevent bone loss, fractures and falls, according to experts.“Osteoporosis is a significant issue in RA and thought to impact 30% to 50% of the population,” Katherine Wysham, MD, assistant professor in the division of rheumatology at the University of Washington, told Healio.
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
📢“You want these patients to be as mobile as possible,” said @DrPess from @UW. Read more about #osteoporosis in #rheumatoidarthritis @HealioRheum 👇 https://t.co/hqaIkPz5O5 https://t.co/5U55atgX7L
-
-
Mashup Score: 2Lupus autoantibody may help ‘awaken the silenced immune system’ to treat ‘cold’ cancers - 3 day(s) ago
An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor therapies used to treat cancers, according to recent findings.“Our findings are raising the possibility that autoantibodies reactive to nucleic acids in lupus play a more active role in promoting immune signaling than previously known,” James Hansen, MD,
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
📢 “These findings establish a new method for stimulating #immune response in silenced tumor environments,” said Dr. James Hansen @YaleRadiology. Read the Q&A about #lupus autoantibodies in #cancer treatment @HealioRheum 👇 https://t.co/wG0GPjwZuj
-
-
Mashup Score: 2Osteoarthritis drawing ‘long overdue’ excitement, but disease modification still elusive - 3 day(s) ago
Although osteoarthritis is receiving more attention in both the research and clinical arenas than ever, all that attention has yet to result in disease-altering treatments, according to experts.“We have got an aging population and OA is on the rise,” Nancy E. Lane, MD, director of the Center for Musculoskeletal Health and endowed professor of medicine and rheumatology at the
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
💡“It has been a long time since we have had an innovative, new class of drug,” Dr. Yusuf Yazici @nyugrossman said of #lorecivivint in #osteoarthritis. Check out @HealioRheum for the full feature 👇 https://t.co/0lzO71IaDr https://t.co/bwSReOGpl6
-
-
Mashup Score: 15
Patients with Sjögren’s disease demonstrate a “pronounced risk” for attempting suicide, with a hazard ratio of 18.054 compared with a general population cohort, according to data published in Scientific Reports.“Individuals with [Sjögren’s syndrome] often experience a significant decline in their health-related quality of life, a deterioration attributed to a range
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
NEW: Study reveals a “pronounced risk” of suicide attempt in patients with #Sjogrens disease Here’s a rundown of the data in @SciReports 👇 https://t.co/SsnRTMFn5M
-
-
Mashup Score: 0Women exhibit lower response to advanced therapies for axial spondyloarthritis vs men - 4 day(s) ago
Women with axial spondyloarthritis are less likely than men to respond to multiple different classes of advanced therapies, according to a systematic review and meta-analysis published in Arthritis Care & Research.“Observational studies indicate that female patients with [axial SpA] have a significantly lower treatment response and are less likely to achieve low disease activity
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
⚠ Women with #axialSpA showed lower response than men to IL-17A and TNF inhibitors, according to a systematic review and meta-analysis. More on the data out of @queensU 👇 https://t.co/3nJa1VYvol
-
-
Mashup Score: 15‘Compelling evidence’: Mycophenolate mofetil best immunosuppressive for systemic sclerosis - 5 day(s) ago
A comparison of immunosuppressive therapies for the treatment of diffuse cutaneous systemic sclerosis found “robust” support for mycophenolate mofetil as the first-line standard of care, according to data published in ACR Open Rheumatology.The drug was superior to methotrexate, steroids and other immunosuppressive therapies for skin and lung outcomes, and was particularly advantageous
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
Mycophenolate mofetil 💪 outperformed methotrexate, steroids and other immunosuppressives for skin and lung outcomes in diffuse cutaneous #SystemicSclerosis More on the data from investigator Dr. Robert Spiera @HSpecialSurgery 👇 https://t.co/rH0CC5ivXy
-
-
Mashup Score: 1Lupus autoantibody may help ‘awaken the silenced immune system’ to treat ‘cold’ cancers - 5 day(s) ago
An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor therapies used to treat cancers, according to recent findings.“Our findings are raising the possibility that autoantibodies reactive to nucleic acids in lupus play a more active role in promoting immune signaling than previously known,” James Hansen, MD,
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
📢 “These findings establish a new method for stimulating #immune response in silenced tumor environments,” said Dr. James Hansen @YaleRadiology. Read the Q&A about #lupus autoantibodies in #cancer treatment @HealioRheum 👇 https://t.co/wG0GPjwZuj
-
-
Mashup Score: 2Osteoarthritis drawing ‘long overdue’ excitement, but disease modification still elusive - 6 day(s) ago
Although osteoarthritis is receiving more attention in both the research and clinical arenas than ever, all that attention has yet to result in disease-altering treatments, according to experts.“We have got an aging population and OA is on the rise,” Nancy E. Lane, MD, director of the Center for Musculoskeletal Health and endowed professor of medicine and rheumatology at the
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
💡“It has been a long time since we have had an innovative, new class of drug,” Dr. Yusuf Yazici @nyugrossman said of #lorecivivint in #osteoarthritis. Check out @HealioRheum for the full feature 👇 https://t.co/0lzO71IaDr https://t.co/bwSReOGpl6
-
-
Mashup Score: 15
Patients with Sjögren’s disease demonstrate a “pronounced risk” for attempting suicide, with a hazard ratio of 18.054 compared with a general population cohort, according to data published in Scientific Reports.“Individuals with [Sjögren’s syndrome] often experience a significant decline in their health-related quality of life, a deterioration attributed to a range
Source: www.healio.comCategories: General Medicine News, RheumatologyTweet-
NEW: Study reveals a “pronounced risk” of suicide attempt in patients with #Sjogrens disease Here’s a rundown of the data in @SciReports 👇 https://t.co/SsnRTMFn5M
-
⚠ Women with #axialSpA showed lower response than men to IL-17A and TNF inhibitors, according to a systematic review and meta-analysis. More on the data out of @queensU 👇 https://t.co/3nJa1VYvol